Market Analysis: November 10th, 2025

Market Analysis: November 10th, 2025

Global Markets

Canadian Markets

Canada’s TSX jumped more than 1% on Monday, from strong gains in the energy and materials sectors as oil and gold prices both moved sharply higher. The rally came amid growing optimism that the U.S. government shutdown could soon come to an end, restoring investor confidence across North American markets.

Shares of Barrick Gold Corp. surged to near a 52-week high, tracking the strength in gold prices as investors sought safe-haven assets amid ongoing global economic uncertainty. The gold rally, supported by expectations of lower U.S. interest rates and persistent inflation concerns, lifted the broader Canadian mining sector.

American Markets

American indexes advanced across the board, as investor sentiment improved following reports of a potential bipartisan resolution to the historic U.S. government shutdown. Technology shares rebounded strongly after last week’s steep sell-off, which was the worst since April that had been driven by fears of an overheated AI sector with stretched valuations.

Nvidia (NVDA) led the recovery, soaring almost 6%, while Tesla (TSLA) climbed over 3% and Alphabet (GOOGL) climbed over 4%, helping lift the Nasdaq Composite to its strongest one-day gain in nearly two months. Analysts noted that investor appetite for high-growth AI-related names remains resilient, suggesting that the recent correction may have presented a buying opportunity for long-term investors.

Scott Bessent, the United States Secretary of the Treasury and economist, suggested that President Donald Trump’s proposed $2,000 “dividend could potentially come in the form of targeted tax cuts, adding further optimism for consumer-facing sectors and growth-sensitive equities.

UBS Securities raised its S&P 500 forecast for 2026 to 7,500, citing expectations of robust corporate earnings and a resilient technology sector. The bank noted that continued AI adoption, productivity gains, and stable macroeconomic conditions could drive earnings growth above trend over the next two years.

European Markets

European markets also climbed more than 1%, led by gains in the technology and mining sectors. However, underlying sentiment remained cautious as new data showed Eurozone investor morale deteriorated more than expected in November, underscoring ongoing concerns about sluggish growth across the region.

UK stocks also advanced, with gains in consumer staples and retail helping the FTSE 100 move higher. However, inflationary pressures continue to weigh on household budgets. According to the Office for National Statistics (ONS) and the British Retail Consortium (BRC), Christmas shopping costs are projected to cost up to 8% more than last year, signaling persistent consumer price pressures.  UK headline inflation remained elevated at 3.8% in September, while food and non-alcoholic beverages rose 4.5% year-over-year. Budget-conscious shoppers continued to flock to discount chains such as Lidl, which retained its position as the UK’s cheapest supermarket in October.

Corporate Stock News

Advanced Chartwell Retirement Residences (CSH.UN:CA) — TD Cowen raised its target price to 23 from 22, citing strong retirement housing demand, continued occupancy and margin improvements, and a solid earnings growth outlook..

Amgen Inc (AMGN) — The company announced that adding its cholesterol drug Repatha to standard therapy reduced major cardiovascular events by 25% in at-risk patients with no prior heart attack or stroke, according to a large study presented at the American Heart Association meeting. The study showed a 36% reduction in first heart attacks, marking the first time a PCSK9 inhibitor demonstrated effectiveness in primary prevention.

Barrick Mining Corp (ABX:CA) — Barrick raised its quarterly dividend, expanded its share buyback program, and exceeded Wall Street expectations for third-quarter profit. The company reported record-high realized gold prices of 3,457 per ounce, up from 2,494 a year earlier, offsetting lower production of 829,000 ounces. Adjusted earnings of 58 cents per share topped expectations of 57 cents.

BlackRock Inc (BLK) — The asset management giant is winding down its Impact Opportunities Fund following the bankruptcy of subprime car lender Tricolor, in which it had invested. The closure marks a retreat from one of BlackRock’s social-impact investment efforts.

Bristol-Myers Squibb Co (BMY) — Piper Sandler lowered its target price to 62 from 64, noting that higher R&D spending offsets improved sales estimates and that investors remain cautious ahead of results from the upcoming Cobenfy study.

Chorus Aviation Inc (CHR:CA) — TD Cowen increased its target price to 31 from 30, reflecting strong cash flow from its Air Canada partnership, potential asset sales, and expansion in its Voyageur business.

Constellation Software Inc (CSU:CA) — Jefferies cut its target price to 4,500 from 5,850, citing lingering investor concerns about AI competition and management transition risks following the CEO change.

Diageo Plc (DEO) — The spirits giant appointed former Tesco CEO Dave Lewis as its next chief executive, effective 2026, to help revive growth and restore profitability. Lewis, known as “Drastic Dave” for his turnaround strategies, joins Diageo amid weaker sales and near-decade-low share prices.

Harley-Davidson Inc (HOG) — D.A. Davidson reduced its target price to 30 from 34, reflecting lower earnings estimates and continued inventory reduction efforts after soft quarterly results.

Honeywell International Inc (HON) — TD Cowen cut its target price to 240 from 250, pointing to decelerating commercial aftermarket growth and lingering supply chain challenges.

KKR & Co Inc (KKR) — The firm agreed to sell aerospace and defense manufacturer Novaria Group to Arcline Investment Management for 2.2 billion, after expanding Novaria through 13 acquisitions since 2020. The sale comes amid strong industry demand and renewed aircraft production growth.

Kits Eyecare Ltd (KITS:CA) — Haywood Securities trimmed its target price to 20 from 21, reflecting a slightly more cautious valuation outlook despite maintaining confidence in the company’s strong growth fundamentals.

Lyft Inc (LYFT) — Jefferies raised its target price to 23 from 22, highlighting growing rideshare demand and improving pricing dynamics in the U.S. market.

Mastercard Inc (MA) and Visa Inc (V) — The payment processors are nearing a settlement with merchants to lower interchange fees and give retailers more flexibility in rejecting certain card types. The proposed deal would reduce average fees by about 0.1 percentage point and relax rules on card acceptance.

MetLife Inc (MET) — Jefferies raised its target price to 104 from 103, citing growth in the Group Benefits segment and support from higher interest rates boosting investment income.

Metsera Inc and Pfizer Inc (PFE) — Pfizer won a 10 billion takeover battle for Metsera, a biotech focused on obesity treatments, outbidding Novo Nordisk. Pfizer will pay 86.25 per share, including cash and contingent value rights worth up to 20.65 per share.

Novo Nordisk A/S (NVO) — The company partnered with India’s Emcure Pharmaceuticals to distribute and market its Poviztra semaglutide injection, a rebranded version of Wegovy. Emcure’s shares rose 6.5% following the announcement.

Nvidia Corp (NVDA) — CEO Jensen Huang said demand for the company’s next-generation Blackwell chips remains exceptionally strong. Nvidia continues expanding its partnership with TSMC to increase wafer supply as demand for AI hardware accelerates globally.

Onex Corp (ONEX:CA) — TD Cowen reduced its target price to 160 from 165, reflecting weaker-than-expected fee-based earnings and slower growth in asset valuations.

Rivian Automotive Inc (RIVN) — The company announced a new CEO pay package worth up to 4.6 billion over 10 years, tied to profitability and share price milestones, mirroring Tesla’s CEO incentive model.

Target Corp (TGT) and Walmart Inc (WMT) — The retail giants launched Thanksgiving promotions emphasizing affordability through private-label brands. Walmart’s 2025 meal offering includes a higher proportion of in-house Great Value products compared to last year, highlighting consumer trade-down trends.

Tenaya Therapeutics Inc (TNYA) — The FDA placed a clinical hold on its TN-201 gene therapy trial for inherited heart disease, requesting standardized patient monitoring protocols and tighter immunosuppression management.

Tesla Inc (TSLA) — The automaker’s China sales plunged 35.8% year-over-year in October to 26,006 units, marking its weakest performance in three years. However, exports of China-made vehicles rose to a two-year high of 35,491 units. Tesla’s head of the Cybertruck program, Siddhant Awasthi, also announced his departure after eight years.

Veon Ltd (VEON) — The telecom group raised its 2025 profit outlook, now expecting EBITDA growth of 16–18%, up from 14–16%, amid surging demand for digital services. Q3 EBITDA rose 20% year-over-year to 524 million, with digital revenue up 63% to 198 million.

Ad